Davis's Drug Guide
insulin glargine/lixisenatide
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
in-soo-lin glar-jeen/lix-i-sen-a-tide
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Soliqua
Ther. Class.
Pharm. Class.
pancreatics
glucagon like peptide 1 glp 1 receptor agonists
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Insulin Glargine/lixisenatide." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110576/all/insulin_glargine_lixisenatide.
Vallerand AHA, Sanoski CAC, . Insulin glargine/lixisenatide. Davis's Drug Guide. F.A. Davis Company; 2025. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110576/all/insulin_glargine_lixisenatide. Accessed May 5, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Insulin glargine/lixisenatide. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110576/all/insulin_glargine_lixisenatide
Vallerand AHA, Sanoski CAC, . Insulin Glargine/lixisenatide [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 May 05]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110576/all/insulin_glargine_lixisenatide.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - insulin glargine/lixisenatide
ID - 110576
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110576/all/insulin_glargine_lixisenatide
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -
